Blood purification in sepsis and systemic inflammation

12Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose of reviewSepsis and septic shock are life-threatening diseases with high mortality. Although efforts have made to improve the survivals, the outcomes are still frustrating. Blood purification was thought to be a promising adjunctive therapy to regulate the excessive cytokine storm or to reduce the endotoxin activity caused by sepsis. Critically ill COVID-19 characterized with the similar disease to sepsis may also benefit from blood purification.Recent findingsThe recent studies mainly focused on hemadsorption materials. The results of the clinical trials showed a tendency in decrease of cytokine levels and endotoxin activity and improvement in haemodynamics. However, the results were controversial. More evidence about blood purification in sepsis and COVID-19 are needed from currently ongoing trials and future well designed trials.SummaryThe blood purification therapy demonstrated the tendency in decrease of cytokines and endotoxin activity in different degree according to the current studies. However, the effect on mortality and haemodynamics is still in controversy. Further well designed, large sample sized studies should focus on the timing of initiating blood purification, the appropriate indications and the optimal type of blood purification membrane or cartridge to provide more evidence for clinical practice.

Cite

CITATION STYLE

APA

Feng, Y., Peng, J. Y., & Peng, Z. (2021, December 1). Blood purification in sepsis and systemic inflammation. Current Opinion in Critical Care. Lippincott Williams and Wilkins. https://doi.org/10.1097/MCC.0000000000000890

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free